Roy's sources point to Case Western research using health records of 1,094,761 adults with type 2 diabetes, reporting a 0.33 hazard ratio for semaglutide versus insulin.
Recap by typeshit. Post by Avi Roy on X.
A brief Facebook post says a daily pill might help people who worry about putting weight back on once they come off Wegovy. It names no drug or study.
In 367 adults with type 2 diabetes, the top combo dose beat 14.8% on tirzepatide alone at 48 weeks. Lilly plans phase 3 by late 2026.
Alessandro Sette's lab will track T cell responses in people before and after starting GLP-1s, including to Parkinson's-linked proteins. He is enrolling himself too.
12:35
Dr. Eric Berg walks through the basics of peptides in a broad explainer. Treat any health claims as his own views.
Ichim announces a peptide he calls the first cancer immunotherapy that also fights aging. The claim is his own and no study details are given.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
Loading…